| 
						
						
						 Canada 
						will not appeal ruling allowing patients to grow own pot 
   Send a link to a friend 
		[March 25, 2016] 
		By Julie Gordon 
		VANCOUVER (Reuters) - Medical marijuana 
		patients in Canada will regain the right to grow their own cannabis 
		after the government said on Thursday it would comply with a federal 
		court decision against a ban introduced by the previous Conservative 
		government. | 
        
            | 
			
			 The federal government said Canada's medical marijuana laws would be 
			rewritten to reflect the court's judgment, setting a deadline of 
			Aug. 24 to finalize the changes. 
 "We are committed, as you know, to making sure that Canadians who 
			require marijuana for medical purposes have appropriate access to 
			that," Health Minister Jane Philpott told reporters in Ottawa, 
			adding that the current law will remain in place until the changes 
			are finalized.
 
 Philpott did not provide specifics on the planned amendments, but 
			noted the government was focused on addressing the issues of 
			accessibility and affordability.
 
			 
			In 2013, the then-ruling Conservative government overhauled Canada's 
			medical marijuana program, requiring that patients buy their 
			cannabis from licensed producers through a mail order system, 
			instead of growing their own marijuana.
 That prompted a group of British Columbia residents to take Canada 
			to court over the ban, which they said was unconstitutional. Last 
			month, a federal court judge in Vancouver agreed with them, striking 
			down the ban.
 
 Medical marijuana is a separate issue from recreational marijuana in 
			Canada. The Liberals, who vaulted to power in October, have pledged 
			to legalize and regulate the recreational use of cannabis, though 
			the time frame remains unclear.
 
			
            [to top of second column] | 
 
			Shares of medical marijuana producers were mixed on Thursday, with 
			Canopy Growth Co closing up 2.36 percent at C$2.60, OrganiGram 
			Holdings flat at 76 Canadian cents and Aphria Inc down 1.29 percent 
			to 77 Canadian cents.
 (Additional reporting by David Ljunggren in Ottawa; Editing by Dan 
			Grebler)
 
 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 
			
			 |